SystImmune
Redmond, United States· Est.
SystImmune is a biopharmaceutical company focused on developing innovative bi-specific and multi-specific antibodies, as well as antibody-drug conjugates (ADCs) for treatment of cancer. Our mission is to create biologics that directly attack the tumor and activate the immune system to enhance anti-tumor responses.
Private Company
Total funding raised: $175M
About
SystImmune is a biopharmaceutical company focused on developing innovative bi-specific and multi-specific antibodies, as well as antibody-drug conjugates (ADCs) for treatment of cancer. Our mission is to create biologics that directly attack the tumor and activate the immune system to enhance anti-tumor responses.
AntibodiesBiologics
Funding History
1Total raised:$175M
Series A$175M